$TNYA SEC Filings

Filed On	Filing
23 Oct 2026	DEFA14A
23 Oct 2026	Proxy statement: special meeting on December 9, 2026
13 Oct 2026	PRE 14A
11 Sep 2026	Form 4: Ali Faraz, Director Received 122,000 shares as a grant or award · Granted 732,500 Stock Option (Right to buy)
11 Sep 2026	Form 4: Tingley Whittemore, Chief Medical Officer Received 49,000 shares as a grant or award · Granted 293,000 Stock Option (Right to buy)
24 Aug 2026	SCHEDULE 13G
17 Aug 2026	Form 4: Ali Faraz, Director Sold 22,232 shares ($15.8K)
17 Aug 2026	Form 4: Tingley Whittemore, Chief Medical Officer Sold 7,424 shares ($5.27K)
17 Aug 2026	144
17 Aug 2026	144
05 Aug 2026	S-8
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition
14 Jul 2026	Form 3: Hyllengren Eric J, Chief Financial Officer No securities owned
14 Jul 2026	Form 4: Hyllengren Eric J, Chief Financial Officer Granted 1,650,000 Stock Option (Right to buy)
02 Jul 2026	8-K: Termination of a Material Definitive Agreement
29 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
29 May 2026	Form 4: Williams R Sanders, Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Walsh Jeffrey T., Director Granted 120,000 Stock Option (Right to buy)
29 May 2026	Form 4: Stehman-Breen Catherine, Director Granted 120,000 Stock Option (Right to buy)

Comments